Sweetch Health App for Chronic Disease ...
Sweetch Health App for Chronic Disease Management
Transforming Patient Engagement: a clinically validated mobile health application which provides a personalised and adaptive intervention platform for chronic disease prevention and management
The Problem
Almost 50% of adults living in developed countries have chronic disease. The World Health Organization indicates that only about 50% of patients with chronic diseases follow treatment recommendations, and only about 20% follow disease prevention recommendations.
Chronic diseases account for 86% of all healthcare spending. Raising adherence to disease prevention and disease management recommendations has greater impact on public health than any improvement in specific medical care.
Sweetch's Solution - a unique personalised experience that can be scaled
In a mobile-first world, people are always connected – but not always available and attentive. Sweetch is a clinically validated Patient Engagement Platform that utilises Artificial Intelligence (AI) to significantly increase patients’ adherence to essential health promotion, disease prevention and disease management recommendations in a highly personalised and scalable way. Sweetch is HIPAA, GDPR and Australian Privacy Act compliant.
Deep Tech – Combining Advanced Data Science with Behavioural Modification
Designed to work in real life, Sweetch’s AI-powered Behavioural Intelligence Engine converts millions of data points originating from a patient's smart phone and other connected devices into contextual, hyper-personalised, just-in-time, just-in-place, recommendations. Through analysing the patient’s current context, past behaviours and real-world capabilities, Sweetch’s proprietary algorithms identify the individual’s compliance patterns and continuously optimise the recommendations that each patient receives. Sweetch’s Just-in-Time Adaptive Intervention approach leads to significantly improved engagement and ultimately improved health outcomes.
Clinical Outcomes
In a clinical trial conducted by Johns Hopkins, Sweetch achieved 86% patient retention and clinically significant effects on weight loss, physical activity increase, and Hemoglobin A1C reduction. Based on these outstanding results, the Hopkins researchers are now commencing a large NIH-funded randomised controlled study.
https://www.jmir.org/2018/2/e72/
One Dynamic Platform for Multiple Chronic Conditions
As an AI-powered solution, Sweetch enables seamless customisation to different disease domains. Sweetch is currently being deployed in four verticals:
- Cardiovascular and Metabolic Areas – Diabetes, Pre-diabetes, Obesity, Coronary Artery Disease, and Atrial Fibrillation;
- Oncology – Breast Cancer and Prostate Cancer;
- Autoimmune Diseases – Rheumatoid Arthritis and IBD; and
- Population Health.
Differentiation
- Deep tech – developed by a leading team of data scientists over the last 5 years, Sweetch is the first mobile health platform to combine predictive analytics and behavioural modification (provisional patent application P-79151-USP3).
- Scalability – fully automated patient engagement platform uniquely positioned for global scaling.
- Flexibility – seamless customisation to different disease domains and corporate partners.
- High cost-efficiency – outcome-based business model.
- Unique Data Asset – by integrating patients’ behavioural data, patients reported outcomes, biometric measures, treatment adherence patterns, and clinical outcomes, Sweetch creates a unique data asset that doesn’t exist today with significant implications on chronic disease prevention and management.
Global Traction
Sweetch’s business partners include Insurers, Pharma Companies, Healthcare Providers, Self-insured Employers and Patient Support Programs spanning across the US, the EU, and APAC. These include, among others –
- Siemens Healthineers;
- WellSpan Health – one of the largest integrated health care systems in Pennsylvania - https://www.prnewswire.com/news-releases/ai-mobile-health-app-sweetch-partners-with-wellspan-health-to-help-fight-diabetes-300741126.html
- Leading global pharma companies – Roche, Sanofi, Janssen, and Novo Nordisk;
- The Baker Institute – Australia’s leading Heart & Diabetes Clinical and ResearchInstitute;
- The National Association of Chronic Disease Directors;
- Icon Group – one of the largest cancer care networks in APAC;
- EMIS – UK’s most popular clinical system (referenced as React2D) - https://www.mobihealthnews.com/content/europe/iqvia-emis-health-partner-support-gps-england-electronically-prescribe-apps-patients
To contact Sweetch about Sweetch Health App for Chronic Disease Management use Get a quote.
The Problem
Almost 50% of adults living in developed countries have chronic disease. The World Health Organization indicates that only about 50% of patients with chronic diseases follow treatment recommendations, and only about 20% follow disease prevention recommendations.
Chronic diseases account for 86% of all healthcare spending. Raising adherence to disease prevention and disease management recommendations has greater impact on public health than any improvement in specific medical care.
Sweetch's Solution - a unique personalised experience that can be scaled
In a mobile-first world, people are always connected – but not always available and attentive. Sweetch is a clinically validated Patient Engagement Platform that utilises Artificial Intelligence (AI) to significantly increase patients’ adherence to essential health promotion, disease prevention and disease management recommendations in a highly personalised and scalable way. Sweetch is HIPAA, GDPR and Australian Privacy Act compliant.
Deep Tech – Combining Advanced Data Science with Behavioural Modification
Designed to work in real life, Sweetch’s AI-powered Behavioural Intelligence Engine converts millions of data points originating from a patient's smart phone and other connected devices into contextual, hyper-personalised, just-in-time, just-in-place, recommendations. Through analysing the patient’s current context, past behaviours and real-world capabilities, Sweetch’s proprietary algorithms identify the individual’s compliance patterns and continuously optimise the recommendations that each patient receives. Sweetch’s Just-in-Time Adaptive Intervention approach leads to significantly improved engagement and ultimately improved health outcomes.
Clinical Outcomes
In a clinical trial conducted by Johns Hopkins, Sweetch achieved 86% patient retention and clinically significant effects on weight loss, physical activity increase, and Hemoglobin A1C reduction. Based on these outstanding results, the Hopkins researchers are now commencing a large NIH-funded randomised controlled study.
https://www.jmir.org/2018/2/e72/
One Dynamic Platform for Multiple Chronic Conditions
As an AI-powered solution, Sweetch enables seamless customisation to different disease domains. Sweetch is currently being deployed in four verticals:
- Cardiovascular and Metabolic Areas – Diabetes, Pre-diabetes, Obesity, Coronary Artery Disease, and Atrial Fibrillation;
- Oncology – Breast Cancer and Prostate Cancer;
- Autoimmune Diseases – Rheumatoid Arthritis and IBD; and
- Population Health.
Differentiation
- Deep tech – developed by a leading team of data scientists over the last 5 years, Sweetch is the first mobile health platform to combine predictive analytics and behavioural modification (provisional patent application P-79151-USP3).
- Scalability – fully automated patient engagement platform uniquely positioned for global scaling.
- Flexibility – seamless customisation to different disease domains and corporate partners.
- High cost-efficiency – outcome-based business model.
- Unique Data Asset – by integrating patients’ behavioural data, patients reported outcomes, biometric measures, treatment adherence patterns, and clinical outcomes, Sweetch creates a unique data asset that doesn’t exist today with significant implications on chronic disease prevention and management.
Global Traction
Sweetch’s business partners include Insurers, Pharma Companies, Healthcare Providers, Self-insured Employers and Patient Support Programs spanning across the US, the EU, and APAC. These include, among others –
- Siemens Healthineers;
- WellSpan Health – one of the largest integrated health care systems in Pennsylvania - https://www.prnewswire.com/news-releases/ai-mobile-health-app-sweetch-partners-with-wellspan-health-to-help-fight-diabetes-300741126.html
- Leading global pharma companies – Roche, Sanofi, Janssen, and Novo Nordisk;
- The Baker Institute – Australia’s leading Heart & Diabetes Clinical and ResearchInstitute;
- The National Association of Chronic Disease Directors;
- Icon Group – one of the largest cancer care networks in APAC;
- EMIS – UK’s most popular clinical system (referenced as React2D) - https://www.mobihealthnews.com/content/europe/iqvia-emis-health-partner-support-gps-england-electronically-prescribe-apps-patients
To contact Sweetch about Sweetch Health App for Chronic Disease Management use Get a quote.
Sweetch Health App is a mobile health application that supports prevention and management of chronic conditions through personalised engagement. Its AI-powered Behavioural Intelligence Engine uses smartphone and connected-device data to tailor recommendations to a person's current context and real-world capabilities. Healthcare providers can adapt the platform to different clinical areas using its flexible customisation options.
- HIPAA, GDPR and Australian Privacy Act compliant
- Johns Hopkins clinical trial recorded 86% patient retention
- Clinically significant trial effects: weight loss, physical activity increase and Hemoglobin A1C reduction
- Business partners span the US, EU and APAC
Source: listing by Sweetch on MedicalSearch · Updated 31 Oct 2026
AI Overview is generated by artificial intelligence and may contain mistakes.
Written by AI from the listing by Sweetch on MedicalSearch. It is meant to use only what that listing says, but it can still get details wrong, so check them with the supplier before you buy.
Thanks for your feedback.
- Your delivery location?
- NSW
- VIC
- QLD
- SA
- WA
- NT
- ACT
- TAS
- New Zealand
- Papua New Guinea
- Afghanistan
- Albania
- Algeria
- Andorra
- Angola
- Antigua and Barbuda
- Argentina
- Armenia
- Austria
- Azerbaijan
- Bahamas
- Bahrain
- Bangladesh
- Barbados
- Belarus
- Belgium
- Belize
- Benin
- Bhutan
- Bolivia
- Bosnia and Herzegovina
- Botswana
- Brazil
- Brunei
- Bulgaria
- Burkina Faso
- Burma
- Burundi
- Cabo Verde
- Cambodia
- Cameroon
- Canada
- Central African Republic
- Chad
- Chile
- China
- Colombia
- Comoros
- Congo (Brazzaville)
- Congo (Kinshasa)
- Costa Rica
- Côte d'Ivoire
- Croatia
- Cuba
- Cyprus
- Czechia
- Denmark
- Djibouti
- Dominica
- Dominican Republic
- Ecuador
- Egypt
- El Salvador
- Equatorial Guinea
- Eritrea
- Estonia
- Ethiopia
- Fiji
- Finland
- France
- Gabon
- Gambia
- Georgia
- Germany
- Ghana
- Greece
- Grenada
- Guatemala
- Guinea
- Guinea-Bissau
- Guyana
- Haiti
- Holy See
- Honduras
- Hungary
- Iceland
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Jamaica
- Japan
- Jordan
- Kazakhstan
- Kenya
- Kiribati
- Korea, North
- Korea, South
- Kosovo
- Kuwait
- Kyrgyzstan
- Laos
- Latvia
- Lebanon
- Lesotho
- Liberia
- Libya
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Madagascar
- Malawi
- Malaysia
- Maldives
- Mali
- Malta
- Marshall Islands
- Mauritania
- Mauritius
- Mexico
- Federated States of Micronesia
- Moldova
- Monaco
- Mongolia
- Montenegro
- Morocco
- Mozambique
- Namibia
- Nauru
- Nepal
- Netherlands
- New Zealand
- Nicaragua
- Niger
- Nigeria
- Norway
- Oman
- Pakistan
- Palau
- Panama
- Papua New Guinea
- Paraguay
- Peru
- Philippines
- Poland
- Portugal
- Qatar
- Romania
- Russia
- Rwanda
- Saint Kitts and Nevis
- Saint Lucia
- Saint Vincent and the Grenadines
- Samoa
- San Marino
- Sao Tome and Principe
- Saudi Arabia
- Senegal
- Serbia
- Seychelles
- Sierra Leone
- Singapore
- Slovakia
- Slovenia
- Solomon Islands
- Somalia
- South Africa
- South Sudan
- Spain
- Sri Lanka
- Sudan
- Suriname
- Swaziland
- Sweden
- Switzerland
- Syria
- Taiwan
- Tajikistan
- Tanzania
- Thailand
- Timor-Leste
- Togo
- Tonga
- Trinidad and Tobago
- Tunisia
- Turkey
- Turkmenistan
- Tuvalu
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- United States
- Uruguay
- Uzbekistan
- Vanuatu
- Venezuela
- Vietnam
- Yemen
- Zambia
- Zimbabwe
- NSW
- VIC
- QLD
- SA
- WA
- NT
- ACT
- TAS
- New Zealand
- Papua New Guinea
- Afghanistan
- Albania
- Algeria
- Andorra
- Angola
- Antigua and Barbuda
- Argentina
- Armenia
- Austria
- Azerbaijan
- Bahamas
- Bahrain
- Bangladesh
- Barbados
- Belarus
- Belgium
- Belize
- Benin
- Bhutan
- Bolivia
- Bosnia and Herzegovina
- Botswana
- Brazil
- Brunei
- Bulgaria
- Burkina Faso
- Burma
- Burundi
- Cabo Verde
- Cambodia
- Cameroon
- Canada
- Central African Republic
- Chad
- Chile
- China
- Colombia
- Comoros
- Congo (Brazzaville)
- Congo (Kinshasa)
- Costa Rica
- Côte d'Ivoire
- Croatia
- Cuba
- Cyprus
- Czechia
- Denmark
- Djibouti
- Dominica
- Dominican Republic
- Ecuador
- Egypt
- El Salvador
- Equatorial Guinea
- Eritrea
- Estonia
- Ethiopia
- Fiji
- Finland
- France
- Gabon
- Gambia
- Georgia
- Germany
- Ghana
- Greece
- Grenada
- Guatemala
- Guinea
- Guinea-Bissau
- Guyana
- Haiti
- Holy See
- Honduras
- Hungary
- Iceland
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Jamaica
- Japan
- Jordan
- Kazakhstan
- Kenya
- Kiribati
- Korea, North
- Korea, South
- Kosovo
- Kuwait
- Kyrgyzstan
- Laos
- Latvia
- Lebanon
- Lesotho
- Liberia
- Libya
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Madagascar
- Malawi
- Malaysia
- Maldives
- Mali
- Malta
- Marshall Islands
- Mauritania
- Mauritius
- Mexico
- Federated States of Micronesia
- Moldova
- Monaco
- Mongolia
- Montenegro
- Morocco
- Mozambique
- Namibia
- Nauru
- Nepal
- Netherlands
- New Zealand
- Nicaragua
- Niger
- Nigeria
- Norway
- Oman
- Pakistan
- Palau
- Panama
- Papua New Guinea
- Paraguay
- Peru
- Philippines
- Poland
- Portugal
- Qatar
- Romania
- Russia
- Rwanda
- Saint Kitts and Nevis
- Saint Lucia
- Saint Vincent and the Grenadines
- Samoa
- San Marino
- Sao Tome and Principe
- Saudi Arabia
- Senegal
- Serbia
- Seychelles
- Sierra Leone
- Singapore
- Slovakia
- Slovenia
- Solomon Islands
- Somalia
- South Africa
- South Sudan
- Spain
- Sri Lanka
- Sudan
- Suriname
- Swaziland
- Sweden
- Switzerland
- Syria
- Taiwan
- Tajikistan
- Tanzania
- Thailand
- Timor-Leste
- Togo
- Tonga
- Trinidad and Tobago
- Tunisia
- Turkey
- Turkmenistan
- Tuvalu
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- United States
- Uruguay
- Uzbekistan
- Vanuatu
- Venezuela
- Vietnam
- Yemen
- Zambia
- Zimbabwe
Thanks for your help!
Sorry! Unable to submit your request at this time. Please try again later.
Report this product
